This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200302-303OCv1 168/12/1462    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, J.-H. Articles by Zhang, H. Search for Related Content PubMed PubMed Citation Articles by Lee, J.-H. Articles by Zhang, H.

Modulation of Bacterial Growth by Tumor Necrosis Factor- In Vitro and In Vivo

Departments of Anaesthesia, Critical Care Medicine and Pathology, Division of Respiratory Medicine, St. Michael's Hospital; Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; and Division of Pulmonary Pharmacology, Research Center Borstel, Borstel, Germany

Correspondence and requests for reprints should be addressed to Haibo Zhang, M.D., Ph.D., Room 9-015, Queen Wing, 30 Bond Street, St. Michael's Hospital, Toronto, ON, M5B 1W8 Canada. E-mail: haibo.zhang{at}utoronto.ca

Tumor necrosis factor- (TNF-) plays an important role in innate immunity. Recent in vitro studies have shown that TNF- may also serve as a growth factor for some bacteria. We examined the physiologic relevance of this phenomenon both in vitro and in vivo. Recombinant mouse TNF- increased in vitro proliferation of Escherichia coli but not Pseudomonas aeruginosa in a concentration-dependent manner, and this effect was attenuated by anti–TNF- antibodies. However, in vivo, TNF- gene-deficient (TNF-^-/-) mice showed higher mortality than wild-type (TNF-^+/+) mice after inoculation of intranasal bacteria. An impaired bacterial clearance in TNF-^-/- mice was associated with decreased systemic concentrations of chemokine macrophage inflammatory protein-2, reduced pulmonary neutrophil recruitment, and depressed expression of neutrophil CD11b and CD16/CD32, suggesting that the effect of TNF- on E. coli growth was outweighed by the recruited neutrophils. We also demonstrated that neutropenic TNF-^+/+ mice had approximately 100-fold higher E. coli counts in their lungs than TNF-^-/- mice, although survival rates in both groups were similar. We conclude that TNF- augments E. coli growth in vitro and in vivo. However, in vivo, this effect becomes only apparent in neutropenic animals. The relevance of these findings for immune compromised patients remains to be investigated.

Key Words: cytokines • phagocytosis • neutrophils • lung • transgenic/knockout

This article has been cited by other articles:

				M. Blankstein, R. J. Byrick, M. Nakane, K.W. A. Bang, J. Freedman, R. R. Richards, O. Kajikawa, R. Zdero, D. Bell, and E. H. Schemitsch Amplified Inflammatory Response to Sequential Hemorrhage, Resuscitation, and Pulmonary Fat Embolism: An Animal Study J. Bone Joint Surg. Am., January 1, 2010; 92(1): 149 - 161. [Abstract] [Full Text] [PDF]

				R. Ramphal, V. Balloy, J. Jyot, A. Verma, M. Si-Tahar, and M. Chignard Control of Pseudomonas aeruginosa in the Lung Requires the Recognition of Either Lipopolysaccharide or Flagellin J. Immunol., July 1, 2008; 181(1): 586 - 592. [Abstract] [Full Text] [PDF]

				J. P. Mizgerd Acute Lower Respiratory Tract Infection N. Engl. J. Med., February 14, 2008; 358(7): 716 - 727. [Full Text] [PDF]

				Yimin and M. Kohanawa A Regulatory Effect of the Balance between TNF-{alpha} and IL-6 in the Granulomatous and Inflammatory Response to Rhodococcus aurantiacus Infection in Mice J. Immunol., July 1, 2006; 177(1): 642 - 650. [Abstract] [Full Text] [PDF]

				R. T. Sadikot, H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D.-s. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell Targeted Immunomodulation of the NF-{kappa}B Pathway in Airway Epithelium Impacts Host Defense against Pseudomonas aeruginosa. J. Immunol., April 15, 2006; 176(8): 4923 - 4930. [Abstract] [Full Text] [PDF]

				S. Yende, E. I. Tuomanen, R. Wunderink, A. Kanaya, A. B. Newman, T. Harris, N. de Rekeneire, S. B. Kritchevsky, and for the Health ABC Study Preinfection Systemic Inflammatory Markers and Risk of Hospitalization Due to Pneumonia Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1440 - 1446. [Abstract] [Full Text] [PDF]

				R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223. [Abstract] [Full Text] [PDF]

				J. P. Mizgerd, M. M. Lupa, J. Hjoberg, J. C. Vallone, H. B. Warren, J. P. Butler, and E. S. Silverman Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1 Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1302 - L1310. [Abstract] [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003 Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300. [Full Text] [PDF]

				J. P. Mizgerd Competing Benefits of Tumor Necrosis Factor-{alpha} for Bacteria and for Host Defense Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1410 - 1411. [Full Text] [PDF]